PLN (phospholamban)
Gene | |
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
5350 |
Gene name
Gene Name - the full gene name approved by the HGNC.
|
Phospholamban |
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
PLN |
Synonyms (NCBI Gene)
Gene synonyms aliases
|
CMD1P, CMH18, PLB |
Disease Acronyms (UniProt)
Disease acronyms from UniProt database
|
CMD1P, CMH18 |
Chromosome
Chromosome number
|
6 |
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
6q22.31 |
Summary
Summary of gene provided in NCBI Entrez Gene.
|
The protein encoded by this gene is found as a pentamer and is a major substrate for the cAMP-dependent protein kinase in cardiac muscle. The encoded protein is an inhibitor of cardiac muscle sarcoplasmic reticulum Ca(2+)-ATPase in the unphosphorylated st |
miRNA
miRNA information provided by mirtarbase database.
|
|||||||||||||||||||||||||
|
Gene ontology (GO)
Gene ontology information of associated ontologies with gene provided by GO database.
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|||||||
|
Protein | |||||||||||
UniProt ID | P26678 | ||||||||||
Protein name | Phospholamban (PLB) | ||||||||||
Protein function | Reversibly inhibits the activity of ATP2A2/SERCA2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+) (PubMed:28890335). Binds preferentially to the ATP-bound E1 conformational form of ATP2A2 which pred | ||||||||||
PDB | 1PLP , 1ZLL , 2HYN , 6Y40 , 7E0Z , 7E11 , 7E12 | ||||||||||
Family and domains |
Pfam
|
||||||||||
Tissue specificity | TISSUE SPECIFICITY: Heart muscle (at protein level). {ECO:0000269|PubMed:17241641}. | ||||||||||
Sequence |
|
||||||||||
Sequence length | 52 | ||||||||||
Interactions | View interactions |
Associated diseases
Disease information provided by ClinVar, GenCC, and GWAS databases.
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|